In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tepnel Life Sciences PLC

Division of Hologic Inc.
www.tepnel.com

Latest From Tepnel Life Sciences PLC

Are Fund Managers Shunning European Biotech?

Despite some recent successes, European biotech remains a less attractive investment opportunity than US biotech, according to most of the panel of European-based health care fund managers interviewed by In Vivo Europe Rx. But all is not lost: some running Europe-only, specialist funds continue to see value in the early stage small-caps.
BioPharmaceutical Europe
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Hologic Inc.
  • Senior Management
  • Benjamin Matzilevich, CEO
    Jeremy Lee, Dir., Fin.
  • Contact Info
  • Tepnel Life Sciences PLC
    Phone: (44) 161 946 2200
    Heron House, Oaks Bus. Park
    Crewe Rd.
    Wythenshawe, M23 9HZ
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register